Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Lipomed
Lipomed
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Deferiprone lipomed
Deferiprone
2018-09-19
2029-2038
Beta-thalassemia
,
Iron overload
Litak
Cladribine
2004-04-14
2024-2038
Non-hodgkin lymphoma
,
Multiple sclerosis
,
B-cell chronic lymphocytic leukemia
,
Hairy cell leukemia
Thalidomide lipomed
Thalidomide
2022-09-19
Renal cell carcinoma
,
Erythema nodosum
,
Behcet syndrome
,
Aphthous stomatitis
,
Rheumatoid arthritis
,
Discoid lupus erythematosus
,
Multiple myeloma
,
Crohn disease
,
Graft vs host disease
,
Waldenstrom macroglobulinemia
,
Langerhans-cell histiocytosis
,
Leprosy
,
Erythema multiforme
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Cladribine
lymphoma
,
b-cell lymphoma marginal zone
Deferiprone
hemochromatosis
,
hemosiderosis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use